Skip to main content

Table 1 Clinical and pathological characteristics of patients with DLBCL in our study

From: An integrated prognosis model of pharmacogenomic gene signature and clinical information for diffuse large B-cell lymphoma patients following CHOP-like chemotherapy

Characteristic Training dataset Validating dataset
(GSE31312) (GSE10846)
Sample size 449 342
Age, years mean (SD) 61.81 (14.75) 61.24 (15.48)
Gender
 Female 189 144
 Male 260 182
 Unknown 0 16
Stage
 1 124 58
 2 96 103
 3 101 77
 4 128 104
 Unknown 0 0
 ≥ 2 Extranodal sites 100 29
 ECOGa performance status > 1 81 84
Microarray subtype
 GCB 214 147
 ABC 193 144
 Unclassified subtype 42 51
 Unknown 0 0
Overall survival
 Time, years mean (SD) 3.24 (2.14) 2.80 (2.35)
 Death 164 148
  1. GCB germinal center B-cell-like subtype, ABC activated B-cell-like subtype, SD standard deviation
  2. aThe Eastern Cooperative Oncology Group (ECOG) performance score ranges from 0 to 3, with a higher score indicating greater impairment